Leading health insurance provider
Bupa has completed the sale of its home healthcare service business to rival company Celesio UK.
The insurer has announced that the sale of Bupa Home Healthcare received approval from the Competition and Markets Authority on June 28.
Following the completed deal, Bupa Home Healthcare will continue to operate from the same offices, where existing teams will still give the same services to patients and customers.
The agreement to sell Bupa Home Healthcare to Celesio UK was first announced in February 2016.
Bupa Home Healthcare is expected to complement Celesio UK’s existing services and strengthen its home healthcare capabilities and national healthcare infrastructure.
“Bupa Home Healthcare is a great fit for Celesio which has a long term commitment to clinical home healthcare and shares our dedication to patients, customers and employees and focus on delivering high quality care,” Bupa UK Managing Director Richard Bowden said in an earlier statement.
“Bupa Home Healthcare joining the Celesio family will enable us to enhance our clinical homecare offering and provide a broader set of services,” added Marc Owen, chairman of the management board of Celesio Group.
The clinical homecare provider supports over 35,000 patients with a range of conditions across the UK. It works in partnership with the National Health Service, the pharmaceutical industry and private medical insurers.
The business, which was bought by Bupa in 2006, employs around 1,000 people who work across the UK.
Related stories:
UK health insurance costs doubled in the past decade
National Friendly to write health policies again
